Trial · NCT07885202
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Cmax | 168 hours after administration | maximum observed plasma concentration |
| Primary | AUC0-t | 168 hours after administration | area under the plasma concentration time curve from time zero to the last measurable concentration |
| Primary | AUC0-∞ | 168 hours after administration | area under the plasma concentration-time curve from time zero to infinity |
| Primary | AUC0-24 | 24 hours after administration | Area under the plasma concentration time curve from time zero to 24 hours |
| Primary | Tmax | 168 hours after administration | time at which Cmax occurs |
| Primary | t1/2 | 168 hours after administration | half life of elimination |
| Primary | Ke | 168 hours after administration | elimination rate constant |
| Primary | CL/F | 168 hours after administration | apparent clearance |
| Primary | Vd/F | 168 hours after administration | apparent volume of distribution during the terminal phase |
| Primary | MRT | 168 hours after administration | mean residence time |
| Primary | Blood-to-plasma concentration ratio | 168 hours after administration | The ratio of drug concentration in whole blood to that in plasma at equilibrium |
| Primary | Plasma protein binding | 168 hours after administration | The fraction of total drug in plasma that is reversibly bound to plasma proteins |
| Primary | AE & SAE | from day1 to day14 after administration | Adverse event \& serious adverse events |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07885202/registered